Cornercap Investment Counsel’s Amphastar Pharmaceuticals AMPH Stock Holding History

Cornercap Investment Counsel’s Portfolio AMPH Stock Details AMPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-5,421	Closed	-$201K	–	173
2024 Q4	$201K	Hold	5,421	–	–	0.06%	450
2024 Q3	$263K	Buy	+5,421	New	+$238K	0.08%	412
2023 Q2	–	Sell	-35,233	Closed	-$1.32M	–	571
2023 Q1	$1.32M	Sell	35,233 -5,813	-14%	-$191K	0.23%	104
2022 Q4	$1.15M	Hold	41,046	–	–	0.2%	146
2022 Q3	$1.15M	Buy	41,046 +10,939	+36%	+$357K	0.22%	127
2022 Q2	$1.05M	Sell	30,107 -16,888	-36%	-$603K	0.18%	190
2022 Q1	$1.69M	Sell	46,995 -11,980	-20%	-$340K	0.19%	123
2021 Q4	$1.37M	Buy	58,975 +1,326	+2%	+$27.1K	0.2%	133
2021 Q3	$1.1M	Sell	57,649 -7,275	-11%	-$142K	0.13%	291
2021 Q2	$1.31M	Buy	64,924 +10,173	+19%	+$192K	0.14%	191
2021 Q1	$1M	Buy	+54,751	New	+$1.02M	0.11%	321
2020 Q4	–	Sell	-20,790	Closed	-$390K	–	438
2020 Q3	$390K	Buy	+20,790	New	+$419K	0.06%	437

Other funds holding AMPH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

EIP

Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Cornercap Investment Counsel's AMPH Position: Q1 2025 in Review

Cornercap Investment Counsel sold out of Amphastar Pharmaceuticals (AMPH) in Q1 2025, closing a stake of 5,421 shares — an estimated $201K sold.

Cornercap Investment Counsel first reported a position in AMPH in Q3 2020 and held it in 12 quarters. The position peaked at $1.69M in Q1 2022. 241 funds tracked by Wall St. Rank hold AMPH as of Q1 2025.

Cornercap Investment Counsel reported no remaining Amphastar Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
Cornercap Investment Counsel sold 5,421 Amphastar Pharmaceuticals shares in Q1 2025, an estimated $201K.
Cornercap Investment Counsel first reported a position in Amphastar Pharmaceuticals in Q3 2020 and held it in 12 quarters.
Cornercap Investment Counsel's Amphastar Pharmaceuticals position peaked at $1.69M in Q1 2022.
241 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q1 2025.

Based on Cornercap Investment Counsel's 13F filing for Q1 2025, filed 2 May 2025.